Harmonization of the intracellular cytokine staining assay

Cancer Immunology, Immunotherapy

Volumn 61, Issue 7, 2012, Pages 967-978

  Welters, Marij J P ^a   Gouttefangeas, Cécile ^b   Ramwadhdoebe, Tamara H ^a   Letsch, Anne ^c   Ottensmeier, Christian H ^d   Britten, Cedrik M ^e   Van Der Burg, Sjoerd H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^e UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Flow cytometry; Harmonization; Intracellular cytokine staining; Proficiency panel; T cells

Indexed keywords

CYTOKINE; GAMMA INTERFERON; HLA ANTIGEN;

ARTICLE; CANCER CHEMOTHERAPY; CELL ACTIVITY; CELL FUNCTION; CELL STRUCTURE; CELL THERAPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTRACELLULAR CYTOKINE STAINING; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SIGNAL NOISE RATIO; T LYMPHOCYTE;

CYTOKINES; FLOW CYTOMETRY; HUMANS; IMMUNOASSAY; IMMUNOTHERAPY, ACTIVE; NEOPLASMS; STAINING AND LABELING;

EID: 84862774274     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-012-1282-9     Document Type: Article

References (28)

1. D Hanahan RA Weinberg 2011 Hallmarks of cancer: the next generation Cell 144 646 674 21376230 10.1016/j.cell.2011.02.013 1:CAS:528:DC%2BC3MXjsFeqtrk%3D
2. J Galon A Costes F Sanchez-Cabo B Kirilovsky Am Mlecnik C Lagorce-Page M Tosolini M Camus A Berger Ph Wind F Zinzindohoue P Bruneval H Cugnenc Z Trajanoski WH Fridman F Page 2006 Type, density, and location of immune cells within human colorectal tumors predict clinical outcome Science 313 1960 1964 17008531 10.1126/science.1129139 1:CAS:528:DC%2BD28XhtVSnsrnK
3. PW Kantoff CS Higano ND Shore ER Berger EJ Small DF Penson CH Redfern AC Ferrari R Dreicer RB Sims Y Xu MW Frohlich PF Schellhammer T Ahmed A Amin J Arseneau N Barth G Bernstein B Bracken P Burch V Caggiano J Chin G Chodak F Chu J Corman B Curti N Dawson JF Deeken T Dubernet M Fishman R Flanigan F Gailani L Garbo T Gardner E Gelmann D George T Godfrey L Gomella M Guerra S Hall J Hanson R Israeli E Jancis MAS Jewett V Kassabian J Katz L Klotz K Koeneman H Koh R Kratzke R Lance J Lech L Leichman R Lemon J Liang J Libertino M Lilly I Malik SE Martin J McCaffrey D McLeod D McNeel B Miles M Murdock C Nabhan J Nemunaitis D Notter A Pantuck P Perrotte D Pessis D Petrylak J Polikoff P Pommerville S Ramanathan M Rarick J Richards R Rifkin N Rohatgi R Rosenbluth R Santucci A Sayegh J Seigne I Shapira N Shedhadeh D Shepherd S Sridhar R Stephenson C Teigland N Thaker J Vacirca L Villa N Vogelzang M Wertheim JH Wolff R Wurzel C Yang J Young 2010 Sipuleucel-T immunotherapy for castration-resistant prostate cancer N Engl J Med 363 411 422 20818862 10.1056/NEJMoa1001294 1:CAS:528:DC%2BC3cXhtVGlurrN
4. FS Hodi SJ O'Day DF McDermott RW Weber JA Sosman JB Haanen R Gonzalez C Robert D Schadendorf JC Hassel W Akerley AJM van den Eertwegh J Lutzky P Lorigan JM Vaubel GP Linette D Hogg CH Ottensmeier C Lebbe C Peschel I Quirt JI Clark JD Wolchok JS Weber J Tian MJ Yellin GM Nichol A Hoos WJ Urba 2010 Improved survival with Ipilimumab in patients with metastatic melanoma N Engl J Med 363 711 723 20525992 10.1056/NEJMoa1003466 1:CAS:528:DC%2BC3cXhtVCrtrbN
5. MJ Welters GG Kenter PJ de Vos van Steenwijk MJ Löwik DM Berends-van der Meer F Essahsah LF Stynenbosch AP Vloon TH Ramwadhdoebe SJ Piersma JM van der Hulst AR Valentijn LM Fathers JW Drijfhout KL Franken J Oostendorp GJ Fleuren CJ Melief SH van der Burg 2010 Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses Proc Nat Acad Sci USA 107 11895 11899 20547850 10.1073/pnas.1006500107 1:CAS:528:DC%2BC3cXovVart7c%3D
6. SH van der Burg 2008 Therapeutic vaccines in cancer: moving from immunomonitoring to immunoquiding Expert Rev Vaccines 7 1 5 18251686 10.1586/14760584.7.1.1
7. HT Maecker A Rinfret P D'Souza J Darden E Roig C Landry P Hayes J Birungi O Anzala M Garcia A Harari I Frank R Baydo M Baker J Holbrook J Ottinger L Lamoreaux CL Epling E Sinclair MA Suni K Punt S Calarota S El-Bahi G Alter H Maila E Kuta J Cox C Gray M Altfeld N Nougarede J Boyer L Tussey T Tobery B Bredt M Roederer R Koup VC Maino K Weinhold G Pantaleo J Gilmour H Horton RP Sekaly 2005 Standardization of cytokine flow cytometry assays BMC Immunol 6 13 15978127 10.1186/1471-2172-6-13
8. MC Jaimes HT Maecker M Yan VC Maino MB Hanley A Greer JM Darden MP D'Souza 2011 Quality assurance of intracellular cytokine staining assays: analysis of multiple rounds of proficiency testing J Immunol Methods 363 143 157 20727897 10.1016/j.jim.2010.08.004 1:CAS:528:DC%2BC3cXhsF2jtLbN
9. HT Maecker JP McCoy M Amos Jr. J Elliott A Gaigalas L Wang R Aranda J Banchereau C Boshoff J Braun Y Korin E Reed J Cho D Hafler M Davis CG Fathman W Robinson T Denny K Weinhold B Desai B Diamond P Gregersen MP Di FO Nestle M Peakman F Villanova J Ferbas E Field A Kantor T Kawabata W Komocsar M Lotze J Nepom H Ochs R O'Lone D Phippard S Plevy S Rich M Roederer D Rotrosen JH Yeh 2010 A model for harmonizing flow cytometry in clinical trials Nat Immunol 11 975 978 20959798 10.1038/ni1110-975 1:CAS:528:DC%2BC3cXhtlSgtbbM
10. SH van der Burg M Kalos C Gouttefangeas S Janetzki C Ottensmeier MJP Welters P Romero CM Britten A Hoos 2011 Harmonization of immune biomarker assays for clinical studies Sci Transl Med 3 108ps44 22072636 10.1126/scitranslmed. 3002785
11. Z Moodie L Price C Gouttefangeas A Mander S Janetzki M Lower MJP Welters C Ottensmeier SH van Der Burg CM Britten 2010 Response definition criteria for ELISPOT assays revisited Cancer Immunol Immunother 59 1489 1501 20549207 10.1007/s00262-010-0875-4 1:STN:280:DC%2BC3cnps1Gmtw%3D%3D
12. A Mander C Gouttefangeas C Ottensmeier MJP Welters L Low SH van der Burg CM Britten 2010 Serum is not required for ex vivo IFN-gamma ELISPOT: a collaborative study of different protocols from the European CIMT Immunoguiding Program Cancer Immunol Immunother 59 619 627 20052465 10.1007/s00262-009-0814-4 1:CAS:528:DC%2BC3cXht12qs7Y%3D
13. CM Britten C Gouttefangeas MJP Welters G Pawelec S Koch C Ottensmeier A Mander S Walter A Paschen J Muller-Berghaus I Haas A Mackensen T Kollgaard P Thor Straten M Schmitt K Giannopoulos R Maier H Veelken C Bertinetti A Konur C Huber S Stevanovic T Wolfel SH van der Burg 2008 The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8(+) T lymphocytes by structural and functional assays Cancer Immunol Immunother 57 289 302 17721783 10.1007/s00262-007-0378-0 1:STN:280:DC%2BD2sjltlyrsg%3D%3D
14. CM Britten S Janetzki SH van der Burg C Huber M Kalos HI Levitsky HT Maecker CJM Melief J O'Donnell-Tormey K Odunsi LJ Old G Pawelec BO Roep P Romero A Hoos MM Davis 2011 Minimal information about T-cell assays: the process of reaching the community of T-cell immunologists in cancer and beyond Cancer Immunol Immunother 60 15 22 21080166 10.1007/s00262-010-0940-z 1:STN:280:DC%2BC3M7ks1KgtA%3D%3D
15. S Janetzki CM Britten M Kalos HI Levitsky HT Maecker CJM Melief LJ Old P Romero A Hoos MM Davis 2009 "MIATA"-Minimal Information about T-cell Assays Immunity 31 527 528 19833080 10.1016/j.immuni.2009.09.007 1:CAS:528:DC%2BD1MXhsVChtL3O
16. SH van der Burg KMC Kwappenberg A Geluk M van der Kruk O Pontesilli E Hovenkamp KLMC Franken KE van Meijgaarden JW Drijfhout THM Ottenhoff CJM Melief R Offringa 1999 Identification of a conserved universal Th epitope in HIV-1 reverse transcriptase that is processed and presented to HIV-specific CD4(+) T-cells by at least four unrelated HLA-DR molecules J Immunol 162 152 160 9886381
17. S Janetzki KS Panageas L Ben-Porat J Boyer CM Britten TM Clay M Kalos HT Maecker P Romero J Yuan WM Kast A Hoos 2008 Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI) Cancer Immunol Immunother 57 303 315 17721781 10.1007/s00262-007-0380-6
18. S Janetzki L Price CM Britten SH van der Burg J Caterini JR Currier G Ferrari C Gouttefangeas P Hayes E Kaempgen V Lennerz K Nihlmark V Souza A Hoos 2010 Performance of serum-supplemented and serum-free media in IFN gamma Elispot Assays for human T-cells Cancer Immunol Immunother 59 609 618 19894047 10.1007/s00262-009-0788-2 1:CAS:528:DC%2BC3cXht12qs7c%3D
19. MC Gauduin 2006 Intracellular cytokine staining for the characterization and quantitation of antigen-specific T lymphocyte responses Methods 38 263 273 16481196 10.1016/j.ymeth.2005.12.004 1:CAS:528:DC%2BD28XivValtL0%3D
20. R Hulspas MR O'Gorman BL Wood JW Gratama DR Sutherland 2009 Considerations for the control of background fluorescence in clinical flow cytometry Cytom B Clin Cytom 76 355 364 10.1002/cyto.b.20485
21. P Lovelace HT Maecker 2011 Multiparameter intracellular cytokine staining Methods Mol Biol 699 165 178 21116983 10.1007/978-1-61737-950-5-8 1:CAS:528:DC%2BC3MXitlWqsg%3D%3D
22. HT Maecker T Frey LE Nomura J Trotter 2004 Selecting fluorochrome conjugates for maximum sensitivity Cytom A 62 169 173
23. HT Maecker J Trotter 2006 Flow cytometry controls, instrument setup, and the determination of positivity Cytom A 69 1037 1042 10.1002/cyto.a.20333
24. L Lamoreaux M Roederer R Koup 2006 Intracellular cytokine optimization and standard operating procedure Nat Protoc 1 1507 1516 17406442 10.1038/nprot.2006.268 1:CAS:528:DC%2BD28Xht1eitL%2FP
25. BE McLaughlin N Baumgarth M Bigos M Roederer SC De Rosa JD Altman DF Nixon J Ottinger J Li L Beckett BL Shacklett TG Evans DM Asmuth 2008 Nine-color flow cytometry for accurate measurement of T-cell subsets and cytokine responses. Part II: panel performance across different instrument platforms Cytom A 73 411 420 10.1002/cyto.a.20556
26. HT Maecker J Moon S Bhatia SA Ghanekar VC Maino JK Payne K Kuus-Reichel JC Chang A Summers TM Clay MA Morse HK Lyerly C DeLaRosa DP Ankerst ML Disis 2005 Impact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOT BMC Immunol 6 17 16026627 10.1186/1471-2172-6-17
27. HT Maecker A Rinfret P D'Souza J Darden E Roig C Landry P Hayes J Birungi O Anzala M Garcia A Harari I Frank R Baydo M Baker J Holbrook J Ottinger L Lamoreaux CL Epling E Sinclair MA Suni K Punt S Calarota S El-Bahi G Alter H Maila E Kuta J Cox C Gray M Altfeld N Nougarede J Boyer L Tussey T Tobery B Bredt M Roederer R Koup VC Maino K Weinhold G Pantaleo J Gilmour H Horton RP Sekaly 2005 Standardization of cytokine flow cytometry assays BMC Immunol 6 13 15978127 10.1186/1471-2172-6-13
28. L Nomura VC Maino HT Maecker 2008 Standardization and optimization of multiparameter intracellular cytokine staining Cytom A 73 984 991 10.1002/cyto.a.20602